Shares of companies with COVID-19 vaccine candidates were mixed in volatile trading Monday, after the promising results from trials of vaccine candidates from Pfizer Inc ( ). (PFE) and BioNTech SE (BNTX) and AstraZeneca PLC ( ). Shares of iBio Inc. (IBIO), which is working with Beijing CC-Pharming Ltd. on a plant-based vaccine to treat the coronavirus ( ), soared 43% in morning trading on volume of 45.5 million shares, which is already nearly double the full-day average. Inovio Pharmaceuticals Inc. (INO), which announced last month ( ) that the Department of Defense will pay $71 million to fund the manufacturing of a device used to administer Inovio vaccines, saw its stock drop 7.9%. Among other companies with vaccine candidates, shares of Moderna Inc. (MRNA) sank 12% in active trading after a J.P. Morgan downgrade on valuation concerns ( ), Novavax Inc. (NVAX) shed 5%, Vaxart Inc. (VXRT) gained 1.9%. Meanwhile, shares of AstraZeneca fell 2.9%, Pfizer gained 1.8% and BioNTech advanced 4.9%. The S&P 500 was up less than 0.1% in morning trading.
-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
July 20, 2020 10:17 ET (14:17 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.